Position in WGS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,663,625
-$839,375 QoQ
Shares Held
82,500
+65.0% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#54
of 223 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WGS Over Time
Shares Held
Position Value (USD)
Derivatives in WGS
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$6,503,000
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Pentwater Capital Management LP holds $5,663,625 across 1 Diagnostics & Research name. WGS ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WGS |
GeneDx Holdings Corp.
This page
|
82,500 | $5,663,625 |
All Filings in WGS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,663,625 | 82,500 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $6,503,000 | 50,000 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $6,503,000 | 50,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $45,789,500 | 425,000 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $2,154,800 | 20,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $36,631,600 | 340,000 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $95,079,300 | 1,030,000 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $1,846,200 | 20,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $112,618,200 | 1,220,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,834,080 | 32,000 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $2,214,125 | 25,000 | Put | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||